Aprea Therapeutics, Inc. 10-Q filing
Filed 2025-11-12 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001104659-25-109867
- Form type
- 10-Q
- CIK
- 0001781983
- Primary document
- https://www.sec.gov/Archives/edgar/data/1781983/000110465925109867/apre-20250930x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aprea Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-10.6M | - | - |
| Net Income | $-10.1M | - | - |
| Eps Basic | -1.65 | - | - |
| Eps Diluted | -1.65 | - | - |
| Cash And Equivalents | $13.7M | - | - |
| Total Assets | $14.3M | - | - |
| Shareholders Equity | $10.9M | - | - |
| Operating Cash Flow | $-9.9M | - | - |
| Capital Expenditures | $15,478 | - | - |